Severe EBV hepatitis treated with valganciclovir

R. Pisapia, A. Mariano, A. Rianda, A. Testa, A. Oliva, L. Vincenzi

Research output: Contribution to journalArticlepeer-review


We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
Issue number1
Publication statusPublished - Feb 2013


  • Epstein-Barr virus infection
  • Hepatitis
  • Therapy
  • Valganciclovir

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Severe EBV hepatitis treated with valganciclovir'. Together they form a unique fingerprint.

Cite this